Literature DB >> 22777759

The CD8+ HLA-DR+ T cells expanded in HIV-1 infection are qualitatively identical to those from healthy controls.

Hiromi Imamichi1, Richard A Lempicki, Joseph W Adelsberger, Rebecca B Hasley, Alice Rosenberg, Gregg Roby, Catherine A Rehm, Amy Nelson, Sonya Krishnan, Mark Pavlick, Christian J Woods, Michael W Baseler, H Clifford Lane.   

Abstract

HIV-induced immune activation leads to expansion of a subset of human CD8(+) T cells expressing HLA-DR antigens. Expansion of CD8(+) HLA-DR(+) T cells can be also observed in non-HIV settings including several autoimmune diseases and aging. Although these cells are felt to represent "immune exhaustion" and/or to be anergic, their precise role in host defense has remained unclear. Here, we report that this subset of cells exhibits a restricted repertoire, shows evidence of multiple rounds of division, but lacks markers of recent TCR engagement. Detailed cell cycle analysis revealed that compared with their CD8(+) HLA-DR(-) counterpart, the CD8(+) HLA-DR(+) T-cell pool contained an increased fraction of cells in S-phase with elevated levels of the G2/M regulators: cyclin A2, CDC25C, Cdc2 (CDK1), indicating that these cells are not truly anergic but rather experiencing proliferation in vivo. Together, these data support a hypothesis that antigen stimulation leads to the initial expansion of a CD8(+) pool of cells in vivo that undergo further expansion independent of ongoing TCR engagement. No qualitative differences were noted between CD8(+) HLA-DR(+) cells from HIV(+) and HIV(-) donors, indicating that the generation of CD8(+) HLA-DR(+) T cells is a part of normal immune regulation that is exaggerated in the setting of HIV-1 infection.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22777759      PMCID: PMC3818066          DOI: 10.1002/eji.201142046

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  37 in total

Review 1.  CDK inhibitors: positive and negative regulators of G1-phase progression.

Authors:  C J Sherr; J M Roberts
Journal:  Genes Dev       Date:  1999-06-15       Impact factor: 11.361

2.  HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies.

Authors:  M Connors; J A Kovacs; S Krevat; J C Gea-Banacloche; M C Sneller; M Flanigan; J A Metcalf; R E Walker; J Falloon; M Baseler; I Feuerstein; H Masur; H C Lane
Journal:  Nat Med       Date:  1997-05       Impact factor: 53.440

3.  T cell abnormalities in mixed connective tissue disease complicated with Klinefelter's syndrome.

Authors:  K Ishihara; M Yoshimura; H Nakao; Y Kanakura; Y Kanayama; Y Matsuzawa
Journal:  Intern Med       Date:  1994-11       Impact factor: 1.271

4.  CD69, CD25, and HLA-DR activation antigen expression on CD3+ lymphocytes and relationship to serum TNF-alpha, IFN-gamma, and sIL-2R levels in aging.

Authors:  I M Rea; S E McNerlan; H D Alexander
Journal:  Exp Gerontol       Date:  1999-01       Impact factor: 4.032

5.  Unscheduled cyclin B expression and p34 cdc2 activation in T lymphocytes from HIV-infected patients.

Authors:  G Piedimonte; D Corsi; M Paiardini; G Cannavò; R Ientile; I Picerno; M Montroni; G Silvestri; M Magnani
Journal:  AIDS       Date:  1999-07-09       Impact factor: 4.177

6.  Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage.

Authors:  J V Giorgi; L E Hultin; J A McKeating; T D Johnson; B Owens; L P Jacobson; R Shih; J Lewis; D J Wiley; J P Phair; S M Wolinsky; R Detels
Journal:  J Infect Dis       Date:  1999-04       Impact factor: 5.226

7.  Simultaneous three-color analysis of the surface phenotype and DNA-RNA quantitation using 7-amino-actinomycin D and pyronin Y.

Authors:  K Toba; E F Winton; T Koike; A Shibata
Journal:  J Immunol Methods       Date:  1995-06-09       Impact factor: 2.303

8.  Cell cycling in HIV infection: analysis of in vivo activated lymphocytes.

Authors:  M Mahalingam; A Pozniak; T J McManus; D Vergani; M Peakman
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

Review 9.  Preventing re-replication of chromosomal DNA.

Authors:  J Julian Blow; Anindya Dutta
Journal:  Nat Rev Mol Cell Biol       Date:  2005-06       Impact factor: 94.444

10.  Control of apoptosis and mitotic spindle checkpoint by survivin.

Authors:  F Li; G Ambrosini; E Y Chu; J Plescia; S Tognin; P C Marchisio; D C Altieri
Journal:  Nature       Date:  1998-12-10       Impact factor: 49.962

View more
  10 in total

1.  Activated CD8(+) T cells and NKT cells in BAL fluid improve diagnostic accuracy in sarcoidosis.

Authors:  A Tøndell; A D Rø; A Åsberg; M Børset; T Moen; M Sue-Chu
Journal:  Lung       Date:  2013-11-10       Impact factor: 2.584

2.  HLA-DR Class II expression on myeloid and lymphoid cells in relation to HLA-DRB1 as a genetic risk factor for visceral leishmaniasis.

Authors:  Bhawana Singh; Michaela Fakiola; Medhavi Sudarshan; Joyce Oommen; Siddharth Sankar Singh; Shyam Sundar; Jenefer M Blackwell
Journal:  Immunology       Date:  2018-11-22       Impact factor: 7.397

3.  Recent Thymus Emigrant CD4+ T Cells Predict HIV Disease Progression in Patients With Perinatally Acquired HIV.

Authors:  Ramia Zakhour; Dat Q Tran; Guenet Degaffe; Cynthia S Bell; Elizabeth Donnachie; Weihe Zhang; Norma Pérez; Laura J Benjamins; Gabriela Del Bianco; Gilhen Rodriguez; James R Murphy; Gloria P Heresi
Journal:  Clin Infect Dis       Date:  2016-02-21       Impact factor: 9.079

4.  Prediction of tumor recurrence by distinct immunoprofiles in liver transplant patients based on mass cytometry.

Authors:  Xuyong Wei; Wentao Xie; Weiwei Yin; Mengfan Yang; Abdul Rehman Khan; Renyi Su; Wenzhi Shu; Binhua Pan; Guanghan Fan; Kun Wang; Fan Yang; Di Lu; Changbiao Li; Linhui Pan; Beini Cen; Haiyang Xie; Li Zhuang; Shusen Zheng; Xun Zeng; Wei Chen; Xiao Xu
Journal:  Am J Cancer Res       Date:  2022-09-15       Impact factor: 5.942

5.  HIV immune activation drives increased Eomes expression in memory CD8 T cells in association with transcriptional downregulation of CD127.

Authors:  Rebecca B Hasley; Changwan Hong; Wenqing Li; Travis Friesen; Yoriko Nakamura; Grace Y Kim; Jung-Hyun Park; Julie A Hixon; Scott Durum; Zonghui Hu; Michael C Sneller; Raphael Oguariri; Tomozumi Imamichi; H Clifford Lane; Marta Catalfamo
Journal:  AIDS       Date:  2013-07-31       Impact factor: 4.177

6.  Dynamics of cytotoxic T cell subsets during immunotherapy predicts outcome in acute myeloid leukemia.

Authors:  Frida Ewald Sander; Anna Rydström; Elin Bernson; Roberta Kiffin; Rebecca Riise; Johan Aurelius; Harald Anderson; Mats Brune; Robin Foà; Kristoffer Hellstrand; Fredrik B Thorén; Anna Martner
Journal:  Oncotarget       Date:  2016-02-16

7.  Level of CD8 T Lymphocytes Activation in HIV-Infected Pregnant Women: In the Context of CD38 and HLA-DR Activation Markers.

Authors:  Stanslaus Musyoki; Simeon Mining; Paul Nyongesa
Journal:  Interdiscip Perspect Infect Dis       Date:  2014-01-22

8.  Potential role for HIV-specific CD38-/HLA-DR+ CD8+ T cells in viral suppression and cytotoxicity in HIV controllers.

Authors:  Stéphane Hua; Camille Lécuroux; Asier Sáez-Cirión; Gianfranco Pancino; Isabelle Girault; Pierre Versmisse; Faroudy Boufassa; Olivier Taulera; Martine Sinet; Olivier Lambotte; Alain Venet
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

9.  Association Between Gut Microbiota and CD4 Recovery in HIV-1 Infected Patients.

Authors:  Wei Lu; Yuqing Feng; Fanhui Jing; Yang Han; Na Lyu; Fei Liu; Jing Li; Xiaojing Song; Jing Xie; Zhifeng Qiu; Ting Zhu; Bertrand Routy; Jean-Pierre Routy; Taisheng Li; Baoli Zhu
Journal:  Front Microbiol       Date:  2018-07-02       Impact factor: 5.640

10.  AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines.

Authors:  Liyang Zhang; John A Zuris; Ramya Viswanathan; Jasmine N Edelstein; Rolf Turk; Bernice Thommandru; H Tomas Rube; Steve E Glenn; Michael A Collingwood; Nicole M Bode; Sarah F Beaudoin; Swarali Lele; Sean N Scott; Kevin M Wasko; Steven Sexton; Christopher M Borges; Mollie S Schubert; Gavin L Kurgan; Matthew S McNeill; Cecilia A Fernandez; Vic E Myer; Richard A Morgan; Mark A Behlke; Christopher A Vakulskas
Journal:  Nat Commun       Date:  2021-06-23       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.